This article is part of the supplement: B cells in autoimmune diseases: Part 1
Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity
Arthritis Research & Therapy 2012, 14(Suppl 5):S1 doi:10.1186/ar3909
No comments have yet been made on this article.
